These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 429095)

  • 1. Diabetogenic action of human growth hormone. Synthesis and activity of C-terminal fragments.
    Wade JD; Ng FM; Bornstein J
    Int J Pept Protein Res; 1979 Feb; 13(2):195-200. PubMed ID: 429095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-potentiating action of human growth hormone. Synthesis and activity of N-terminal fragments.
    Pullin CO; Harcourt JA; Ng FM; Bornstein J
    Int J Pept Protein Res; 1981 Sep; 18(3):318-23. PubMed ID: 7042618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of C-terminal chain shortening on the insulin-antagonistic activity of human growth hormone 177--191.
    Wade JD; Ng FM; Bornstein J; Pullin CO; Pearce JS
    Acta Endocrinol (Copenh); 1982 Sep; 101(1):10-4. PubMed ID: 6751009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A hybrid noncovalent complex of fragments of porcine and human growth hormones with diabetogenic activity.
    Gennick SE; Kostyo JL; Mills JB; Eden S
    Endocrinology; 1983 Jun; 112(6):2069-75. PubMed ID: 6303758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A recombinant-DNA-derived modification of human growth hormone (hGH44-191) with enhanced diabetogenic activity.
    Lewis UJ; Lewis LJ; Salem MA; Staten NR; Galosy SS; Krivi GG
    Mol Cell Endocrinol; 1991 Jun; 78(1-2):45-54. PubMed ID: 1936524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperglycemic action of synthetic C-terminal fragments of human growth hormone.
    Ng FM; Bornstein J
    Am J Physiol; 1978 May; 234(5):E521-6. PubMed ID: 645904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complementation of human growth hormone (GH) peptide 1-134 with C-terminal fragments of human GH produced by digestion with bromelain.
    Thorson JA; Sauder SE; Gennick SE; Kostyo JL; Mills JB
    Endocrinology; 1983 Mar; 112(3):782-7. PubMed ID: 6822209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that the N-terminus of human growth hormone is involved in expression of its growth promoting, diabetogenic, and insulin-like activities.
    Towns R; Kostyo JL; Vogel T; Sakal E; Tchelet A; Maher R; Gertler A
    Endocrinology; 1992 Mar; 130(3):1225-30. PubMed ID: 1537288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human somatotropin 53. Synthesis and biological activity of the amino terminal fifty-four residue fragment.
    Noble RL; Yamashiro D; Li CH
    Int J Pept Protein Res; 1977 Nov; 10(5):385-93. PubMed ID: 604288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of response to insulin and anti-insulin action by two human pituitary peptides in lean agouti A/a, obese yellow Avy/A, and C57BL/6J-ob/ob mice.
    Salem MA; Wolff GL
    Proc Soc Exp Biol Med; 1989 Jun; 191(2):113-23. PubMed ID: 2657747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of constrained peptide analogues related to the N-terminal region of human growth hormone.
    Ede NJ; Lim N; Rae ID; Ng FM; Hearn MT
    Pept Res; 1991; 4(3):171-6. PubMed ID: 1823187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human somatotropin. 55. Synthesis and growth-promoting activity of peptide analogs of the carboxyl terminal plasmin fragment.
    Blake J; Li CH
    Int J Pept Protein Res; 1978 May; 11(5):315-22. PubMed ID: 681075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and properties of human growth hormone fragments.
    Peña C; Stewart JM; Ferrara P; Paladini AC
    Int J Pept Protein Res; 1981 Sep; 18(3):289-96. PubMed ID: 7341522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the amino-terminal portion of human growth hormone on glucose clearance and metabolism in normal, diabetic, hypophysectomized, and diabetic-hypophysectomized rats.
    Salem MA
    Endocrinology; 1988 Sep; 123(3):1565-76. PubMed ID: 3042372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of an antilipogenic fragment of human growth hormone on glucose transport in rat adipocytes.
    Wijaya E; Ng FM
    Biochem Mol Biol Int; 1993 Nov; 31(3):543-52. PubMed ID: 8118430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analyses of insulin-potentiating fragments of human growth hormone by computative simulation; essential unit for insulin-involved biological responses.
    Ohkura K; Hori H
    Bioorg Med Chem; 2000 Jul; 8(7):1733-40. PubMed ID: 10976521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoglycemic action of a novel constrained analog of human growth hormone-(6-13).
    Lim N; Ng FM; Wu ZM; Ede N; Hearn MT
    Endocrinology; 1992 Aug; 131(2):835-40. PubMed ID: 1639027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic effect of a hypoglycaemic fragment of human growth hormone (hGH 6-13).
    Ng FM; Rotstein T
    Diabetes Res; 1988 Mar; 7(3):103-8. PubMed ID: 3046817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biosynthetic 20-kilodalton methionyl-human growth hormone has diabetogenic and insulin-like activities.
    Kostyo JL; Cameron CM; Olson KC; Jones AJ; Pai RC
    Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4250-3. PubMed ID: 3889926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased sensitivity of adipose tissue to insulin after in vivo treatment of yellow Avy/A obese mice with amino-terminal peptides of human growth hormone.
    Frigeri LG; Teguh C; Ling N; Wolff GL; Lewis UJ
    Endocrinology; 1988 Jun; 122(6):2940-5. PubMed ID: 3131129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.